MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (Nasdaq) today under the symbol "MMED" in connection with its initial public offering (IPO). Members of MiniMed's leadership team, including Chief Executive Officer Que Dallara, will celebrate this milestone by ringing the Nasdaq's Opening Bell this morning.